Marked HDL deficiency and premature coronary heart disease

Current Opinion in Lipidology

Volumn 21, Issue 4, 2010, Pages 289-297

  Schaefer, Ernst J ^a,b   Santos, Raul D ^c   Asztalos, Bela F ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

apolipoprotein A I deficiency; ATP binding cassette A1 transporter dysfunction; coronary heart disease; high density lipoprotein deficiency; lecithin: cholesterol acyltransferase deficiency; Tangier disease

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PRE BETA HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ABC TRANSPORTER; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

AMINO ACID SUBSTITUTION; AMYLOIDOSIS; ANEMIA; ANGIOCARDIOGRAPHY; CHOLESTEROL BLOOD LEVEL; CORNEA OPACITY; FAMILIAL DISEASE; GENE DELETION; GENE MUTATION; HUMAN; HYPOALPHALIPOPROTEINEMIA; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY FAILURE; LIPOPROTEIN DEFICIENCY; PRIORITY JOURNAL; REVIEW; TANGIER DISEASE; XANTHOMA; COMPLICATION; CORONARY ARTERY DISEASE; DEFICIENCY; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE;

AMYLOIDOSIS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CORONARY DISEASE; HUMANS; LIPOPROTEINS, HDL; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 77954957285     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32833c1ef6     Document Type: Review

References (13)

1. Santos RD, Schaefer EJ, Asztalos BF, et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency. J Lipid Res 2008; 46:349-357.
2. Santos RD, Miname MH, Martinez LR, et al. Noninvasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multidetector row computed tomography angiography. Atherosclerosis 2008; 197:910-915.
3. Santos RD, Miname L, Asztalos BF, et al. Clinical presentation, laboratory values, and coronary heart disease risk in marked high density lipoprotein deficiency states. J Clin Lipidol 2008; 2:237-247.
4. Wada M, Iso T, Asztalos BF, et al. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion). Atherosclerosis 2009; 207:157-161.
5. Favari E, Calabresi L, Adorni MP, et al. Small discoidal prebeta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. Biochemistry 2009; 48:11067-11074.
6. Palmiero PM, Sbeity Z, Liebmann J, Ritch R. In vivo imaging of the cornea in a patient with lecithin-cholesterol acytransferase deficiency. Cornea 2009; 28:1061-1064.
7. Baass A, Wassef H, Tremblay M, et al. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene in FLD phenotype. Atherosclerosis 2009; 207:452-457.
8. Park CW, Lim MH, Youn DY, et al. Two novel frameshift mutations in lecithin-cholesterol acyltransferase (LCAT) gene associated with a familial LCAT deficiency phenotype. Atherosclerosis 2009; 206:346-348.
9. Calabresi L, Favari E, Moleri E, et al. Functional LCAT is not required for macrophage cholesterol efflux to human serum. Atherosclerosis 2009; 204:141-146.
10. Eriksson M, Schonland S, Yumlu S, et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. J Mol Diagn 2009; 11:257-262.
11. Barlage S, Gnewuch C, Liebisch G, et al. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activitation. Intensive Care Med 2009; 3:1877-1885.
12. Pays E, Vanhollebeke B. Human innate immunity against African trypanosomes. Curr Opin Immunol 2009; 21:493-498.
13. Asztalos BF, Brunzell J. The kinetics and remodeling of HDL particles: lessons from inborn errors of lipid metabolism. In: Schaefer EJ, editor. High density lipoproteins, dyslipidemia, and coronary heart disease. New York: Springer Publishing; 2010. pp. 33-44.